A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

NCT00864253 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

529

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: ABI-007
DRUG: Dacarbazine

Sponsor

Celgene

Collaborators

[object Object]